Kenji Yokoi

Kenji Yokoi, MD, PhD

Associate Professor of Nanomedicine, Academic Institute
Associate Member, Research Institute
Houston Methodist


Dr. Yokoi received his M.D. degree in 1992 and Ph.D. degree in 1997 from the Kanazawa University, School of Medicine and Graduate School of Medicine respectively. Dr. Yokoi completed his postgraduate research fellowship at the University of Texas MD Anderson Cancer Center in Houston, TX. He then accepted a position as an instructor in the Department of Cancer Biology at MD Anderson and as an instructor of general and cardiothoracic surgery for Kanazawa University Hospital in Japan.

He was appointed to the position of assistant professor in the department of cancer biology at MD Anderson in 2007 and then as an assistant member in the department of nanomedicine in The Methodist Hospital Research Institute in 2011. Dr. Yokoi has also held the position of visiting scientist in the department of cancer biology at MD Anderson since 2011 and guest researcher for the Cancer Research Institute of Kanazawa University since 2008-present.

Description of Research

Dr. Yokoi’s develops novel therapies and imaging techniques for cancer using nanotechnologies. His basic research program defines the structure-permeability of tumor associated vessels to nanoparticles using various orthotopic mouse models of cancer. The over goal of these studies is to develop personalized therapy for cancer based on selection strategies that define the optimal drug loaded nanoparticles for a patient, based on the biodistribution properties of nanoparticles.

Areas Of Expertise

Nanomedicine Nanotechnology Drug delivery Imaging Cancer Biology
Education & Training

PhD, Kanazawa University Graduate School of Medicine
Postdoctoral Fellowship, University of Texas MD Anderson Cancer Center

Attenuated microcirculation in small metastatic tumors in murine liver
Ziemys, A, Simic, V, Milosevic, M, Kojic, M, Liu, YT & Yokoi, K 2021, , Pharmaceutics, vol. 13, no. 5, 703.

Seed-and soil-dependent differences in murine breas tumor microenvironments dictate anti-PD-L1 IgG delivery and therapeutic efficacy
Liu, YT, Goel, S, Kai, M, Guerrero, JAM, Nguyen, T, Mai, J, Shen, H, Ziemys, A & Yokoi, K 2021, , Pharmaceutics, vol. 13, no. 4, 530.

Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Mai, J, Li, Z, Xia, X, Zhang, J, Li, J, Liu, H, Shen, J, Ramirez, M, Li, F, Li, Z, Yokoi, K, Liu, X, Mittendorf, EA, Ferrari, M & Shen, H 2021, , Advanced Science.

Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy
Kai, M, Ziemys, A, Liu, YT, Kojic, M, Ferrari, M & Yokoi, K 2019, , Translational Oncology, vol. 12, no. 9, pp. 1196-1205.

Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance
Ziemys, A, Yokoi, K, Kai, M, Liu, YT, Kojic, M, Simic, V, Milosevic, M, Holder, AM & Ferrari, M 2018, , Journal of Controlled Release, vol. 291, pp. 99-105.

Tumor progression effects on drug vector access to tumor-associated capillary bed
Kiseliovas, V, Milosevic, M, Kojic, M, Mazutis, L, Kai, M, Liu, YT, Yokoi, K, Ferrari, M & Ziemys, A 2017, , Journal of Controlled Release, vol. 261, pp. 216-222.

Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma
Borsoi, C, Leonard, F, Lee, Y, Zaid, M, Elganainy, D, Alexander, JF, Kai, M, Liu, YT, Kang, Y, Liu, X, Koay, EJ, Ferrari, M, Godin, B & Yokoi, K 2017, , Cancer Letters, vol. 403, pp. 296-304.

Macrophage polarization contributes to the anti-tumoral efficacy of mesoporous nanovectors loaded with albumin-bound paclitaxel
Leonard, F, Curtis, LT, Ware, MJ, Nosrat, T, Liu, X, Yokoi, K, Frieboes, HB & Godin, B 2017, , Frontiers in immunology, vol. 8, no. JUN, 693.

Integrated Microfluidic System for Gene Silencing and Cell Migration
Liu, Z, Han, X, Zhou, Q, Chen, R, Fruge, S, Jo, MC, Ma, Y, Li, Z, Yokoi, K & Qin, L 2017, , Advanced Biosystems, vol. 1, no. 6, 1700054.

Integrated Microfluidic System for Gene Silencing and Cell Migration
Liu, Z, Han, X, Zhou, Q, Chen, R, Fruge, S, Jo, MC, Ma, Y, Li, Z, Yokoi, K & Qin, L 2017, , Advanced Biosystems, vol. 1, no. 6, 1700054.

Nanoplasmonic quantification of tumour-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring
Liang, K, Liu, F, Fan, J, Sun, D, Liu, C, Lyon, CJ, Bernard, DW, Li, Y, Yokoi, K, Katz, MH, Koay, EJ, Zhao, Z & Hu, Y 2017, , Nature Biomedical Engineering, vol. 1, no. 4, 0021.

Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics
Ziemys, A, Klemm, S, Milosevic, M, Yokoi, K, Ferrari, M & Kojic, M 2016, , Drug Delivery, vol. 23, no. 7, pp. 2524-2531.

Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions
Leonard, F, Curtis, LT, Yesantharao, P, Tanei, T, Alexander, JF, Wu, M, Lowengrub, J, Liu, X, Ferrari, M, Yokoi, K, Frieboes, HB & Godin, B 2016, , Nanoscale, vol. 8, no. 25, pp. 12544-12552.

A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: A new strategy for heart failure diagnostics and therapeutics
Ruiz-Esparza, GU, Segura-Ibarra, V, Cordero-Reyes, AM, Youker, KA, Serda, RE, Cruz-Solbes, AS, Amione-Guerra, J, Yokoi, K, Kirui, DK, Cara, FE, Paez-Mayorga, J, Flores-Arredondo, JH, Guerrero-Beltrán, CE, Garcia-Rivas, G, Ferrari, M, Blanco, E & Torre-Amione, G 2016, , European Journal of Heart Failure, vol. 18, no. 2, pp. 169-178.

The protein kinase promiscuities in the cancer-preventive mechanisms of NSAIDs
Norvaisas, P, Chan, D, Yokoi, K, Dave, B & Ziemys, A 2016, , European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), vol. 25, no. 1, pp. 77-84.

Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier
Yokoi, K, Chan, D, Kojic, M, Milosevic, M, Engler, D, Matsunami, R, Tanei, T, Saito, Y, Ferrari, M & Ziemys, A 2015, , Journal of Controlled Release, vol. 217, pp. 293-299.

Capillary collagen as the physical transport barrier in drug delivery to tumor microenvironment
Ziemys, A, Yokoi, K & Kojic, M 2015, , Tissue Barriers, vol. 3, no. 3, pp. e1037418.

Microfluidic cytometric analysis of cancer cell transportability and invasiveness
Liu, Z, Lee, Y, Jang, JH, Li, Y, Han, X, Yokoi, K, Ferrari, M, Zhou, L & Qin, L 2015, , Scientific Reports, vol. 5, 14272.

Retinal synaptic regeneration via microfluidic guiding channels
Su, PJ, Liu, Z, Zhang, K, Han, X, Saito, Y, Xia, X, Yokoi, K, Shen, H & Qin, L 2015, , Scientific Reports, vol. 5, 13591.

A new imaging platform for visualizing biological effects of non-invasive radiofrequency electric-field cancer hyperthermia
Corr, SJ, Shamsudeen, S, Vergara, LA, Chak-Shing Ho, J, Ware, MJ, Keshishian, V, Yokoi, K, Savage, DJ, Meraz, IM, Kaluarachchi, W, Cisneros, BT, Raoof, M, Nguyen, DT, Zhang, Y, Wilson, LJ, Summers, H, Rees, P, Curley, SA & Serda, RE 2015, , PLoS ONE, vol. 10, no. 8, e0136382.